EN DE

Shanghai Aladdin Biochemical Technology Co (688179) Fair Value & Analysis

Basic Materials · CN · Market cap 7.6B CNY

SA Shanghai Aladdin Biochemical Technology Co 688179 · SHG
Price¥21.42
Fair Value¥4.79
Upside-77.6%
Quality62/100
Watch Shanghai Aladdin Biochemical Technology Co for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 14.5% net margin
Moderate debt · generates free cash flow
0.68% dividend yield
Mixed vs. peers (6/14)
Moderate moat 63/100
Evidence: Medium Range ¥3.59 – ¥5.99 Share as image

Fair value as of: Aug 11, 2026

From 26 valuation models · updated 2 days ago

Share price −10.7% over the past month.

A solid business, but screening 78% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥5.99). The favourable scenario is already priced in.
  • Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥42.86 ¥6.33 Fair Value ¥4.79 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 11, 2026.

How to read this chart

60‑month range ¥6.33 – ¥42.86 · fair‑value band ¥3.59 – ¥5.99 · the ¥21.42 price screens above the ¥4.79 fair value. Dashed = 300-day average. As of Aug 11, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Shanghai Aladdin Biochemical Technology Co (688179) currently trades at ¥21.42, while our model-based Fair Value estimate is ¥4.79, implying the stock looks roughly 77.6% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Shanghai Aladdin Biochemical Technology Co generated revenue of 736M CNY at a net margin of 14.5%. Revenue grew 31.2% year over year. It earns a return on equity of 12.2%. The stock trades on a trailing P/E of 64.3. Fundamentals as of Aug 11, 2026

Our scenario range runs from ¥3.59 (bear case) to ¥5.99 (bull case); at ¥21.42, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 90% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -46% fair-value upside, at -78%, 688179 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ¥14.65 ¥26.22 ¥48.86 80
Residual Income ¥2.37 ¥2.63 ¥3.79 76
Rev-Margin DCF ¥6.24 ¥9.81 ¥16.25 74
All 26 models by family
DCF Models
FCF DCF ¥15.59 ¥23.92 ¥49.91 38
Owner Earnings ¥3.80 ¥8.24 ¥17.23 31
5Y Revenue Exit ¥6.15 ¥8.57 ¥13.45 39
5Y EBITDA Exit ¥7.96 ¥12.22 ¥20.50 41
5Y P/E Exit ¥7.21 ¥12.99 ¥20.36 38
10Y Revenue Exit ¥9.00 ¥15.01 ¥17.41 36
10Y EBITDA Exit ¥10.38 ¥18.81 ¥32.20 37
10Y P/E Exit ¥9.84 ¥17.24 ¥28.23 35
Earnings-Based
Graham-Dodd ¥1.92 ¥13.37 ¥18.76 54
Lynch FV ¥5.24 ¥7.49 ¥9.74 50
PEG = 1.0 ¥5.24 ¥7.49 ¥9.74 46
EPV ¥3.84 ¥4.42 ¥4.92 59
Dividend Discount
Gordon GGM ¥1.71 ¥3.41 ¥5.16 70
DDM Multi-Stage ¥1.71 ¥2.94 ¥3.60 61
Multiples
P/E Multiple ¥3.59 ¥4.79 ¥5.99 63
P/S Multiple ¥2.16 ¥2.88 ¥3.60 58
P/B Multiple ¥3.59 ¥4.79 ¥5.99 55
EV/EBIT ¥5.54 ¥7.35 ¥9.15 53
EV/EBITDA ¥4.75 ¥6.28 ¥7.82 54
EV/Revenue ¥2.16 ¥3.02 ¥3.89 43
Asset-Based
NCAV (Graham) ¥1.34 ¥1.79 ¥2.68 50
Growth DCF
Growth DCF ¥14.65 ¥26.22 ¥48.86 80
Rev-Margin DCF ¥6.24 ¥9.81 ¥16.25 74
Economic Profit
Residual Income ¥2.37 ¥2.63 ¥3.79 76
ROIC Compounder ¥4.82 ¥6.90 ¥8.36 72
Growth Earnings
Growth-Adj P/E ¥6.15 ¥8.78 ¥11.41 68

Widest divergence: DCF Models (¥12.99) versus Asset-Based (¥1.79). Highest evidence: Growth DCF (80).

Notify me when 688179 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 736M CNY
Revenue growth (YoY) +31.2%
Net margin 14.5%
Return on equity 12.2%
Free cash flow 352M CNY FY2025
P/E ratio 64.3
More key figures
Operating margin 26.4%
EPS (TTM) ¥0.3200
Dividend yield 0.7%
EPS growth (YoY) +14.3%

Figures from reported company fundamentals · as of Aug 11, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100

Of which business quality 63 · Market factors (momentum, volatility) 61

Profitability 37
Margins and returns on capital today
Quality Growth 48
Are margins and returns improving?
Cashflow 97
Earnings quality: real cash, not paper profit
Fin. Strength 80
Balance sheet, leverage, solvency risk
Investment 57
Disciplined investing over empire-building
Low Volatility 46
Calm price path (market factor)
Momentum 71
Price trend over the last 3–12 months (market factor)
52W Momentum 62
Distance to the 52-week high (market factor)
Net Issuance 42
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents in China and internationally.

Full company description

Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents in China and internationally. It offers chemistry and biochemicals reagents, including blocks, ligands, catalysts, chemical synthesis, laboratory chemicals, chemical biology, analytical standards, CVD and ALD precursors, and stable isotopes; material science solutions for energy, electronic, and biomedical materials; and small molecules, such as compound libraries, ligand families, antibody-drug conjugates, and protein degradation-targeting chimeras, as well as classification by signaling pathway, target toxin, and disease. The company also provides life sciences comprising protein, antibody, and molecular, protein, and cell biology; GMP-grade products, which include bioactive small molecules, grade protein, upstream process chemicals, downstream process and formulation chemicals, and culture medium and buffer raw materials. In addition, it offers laboratory equipment, such as miscellaneous tools; tweezers, scrapers, and tools; PCR supplies and equipment; balance, scale, and weighing tools; sealing film, foil, and tape; filtration and chromatography; microscopes and microscope slides; liquid handling and dispensing; sample processing; glassware; and safety, gloves, eyeglasses, and cleaning products. The company sells its reagents products under the Aladdin brand and its experimental consumables under the Core Silicon Valley brand through its e-commerce platform. Its products are used in analytical chemistry, chemical synthesis, materials science and engineering, biopharmaceutical production, drug discovery, and genomics applications. The company was founded in 2008 and is based in Shanghai, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Shanghai Aladdin Biochemical Technology Co reported revenue of ¥696M in FY2025 versus ¥288M in FY2021, a compound +24.7%/yr. Reported net income was ¥102M in FY2025, compounding +3.4%/yr from FY2021.

Growth Quality 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
696M CNY
Latest YoY
+30.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+22.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+24.3%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+22.1%
Revenue +24.7%/yr
FY21 ¥288M
FY22 ¥378M
FY23 ¥403M
FY24 ¥534M
FY25 ¥696M
Net income +3.4%/yr
FY21 ¥89.4M
FY22 ¥92.8M
FY23 ¥85.8M
FY24 ¥98.8M
FY25 ¥102M

688179 screens 78% overvalued. Compare with BASF SE →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Shanghai Aladdin Biochemical Technology Co Fair Value". https://www.fairvalue-calculator.com/stock/688179

Peer Group

Chemicals · 341 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 62 · Top 25%
Fair Value upside −78% · Bottom 25%
Return on equity (TTM) 12% · Top 25%
Return on assets 5% · Top 25%
Net margin (TTM) 15% · Top 25%
Operating margin (TTM) 26% · Top 25%
Revenue growth 31% · Top 25%
Dividend yield (TTM) 0.7% · Below median
Debt / equity 0.67× · Higher than 75% of peers

Valuation Multiples vs Chemicals median · lower = cheaper

P/E (TTM) 65.8× · Pricier than 75% of peers
P/B 7.87× · Pricier than 75% of peers
P/S (TTM) 10.36× · Pricier than 75% of peers
P/FCF 3.2× · Pricier than median
EV/EBITDA 35.8× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 21
PAST 49 · sector 19
HEALTH 67 · sector 94
DIVIDEND 14 · sector 27

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 11, 2026).

Stock Price Fair Value vs Fair Value
BASF SE BASN 1,034 MXN 532.13 MXN -49%
Ningxia Baofeng Energy Group 600989 ¥20.32 ¥20.17 -1%
Zhejiang Juhua Co 600160 ¥42.85 ¥23.35 -46%
PT Barito Pacific Tbk, BRPT 1,690 IDR 1,628 IDR -4%
LG Chem, Ltd 051910 260,500 KRW 587,755 KRW +126%
Formosa Chemicals & Fibre Corporation 1326 66.10 TWD 6.79 TWD -90%
PTT Global Chemical Public Company PTTGC 35.50 THB 18.21 THB -49%
542812 542812 ₹4,369 ₹791.05 -82%
Indorama Ventures Public Company IVL 24.50 THB 17.95 THB -27%
Navin Fluorine International Limited NAVINFLUOR ₹8,650 ₹2,146 -75%

Compare Shanghai Aladdin Biochemical Technology Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Shanghai Aladdin Biochemical Technology Co (688179) overvalued or undervalued?
As of Aug 11, 2026, our model estimates a fair value of ¥4.79 versus a price of ¥21.42, about −78% (overvalued).
What is the fair value of 688179?
Our model-based fair value for Shanghai Aladdin Biochemical Technology Co is ¥4.79 (as of Aug 11, 2026), built from audited fundamentals. The current price is ¥21.42.
What is the quality score of 688179?
Shanghai Aladdin Biochemical Technology Co has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Shanghai Aladdin Biochemical Technology Co (688179)?
Shanghai Aladdin Biochemical Technology Co reported trailing-twelve-month revenue of about 736M CNY (latest available figure, as of Aug 11, 2026).
What is the net profit margin of 688179?
The net profit margin of Shanghai Aladdin Biochemical Technology Co is about 14.5%, meaning it keeps roughly 14.5% of revenue as net income. Based on the latest reported figures.
Does Shanghai Aladdin Biochemical Technology Co pay a dividend?
Shanghai Aladdin Biochemical Technology Co currently shows a dividend yield of about 0.69% relative to its recent price (as of Aug 11, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Shanghai Aladdin Biochemical Technology Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.